SCHEMBL623772

SCHEMBL623772

N=C1NC(=O)/C(=C\c2ccc(-c3ccccc3Cl)o2)S1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 10/20 1.00
GSK3A P49840 8/20 1.00
PIK3CG P48736 3/20 0.78
IGF1R P08069 3/20 0.76
INSR P06213 2/20 0.76
CDK2 P24941 5/20 0.69
MEN1 O00255 2/20 0.64
POLB P06746 2/20 0.64
KMT2A Q03164 2/20 0.64
ALDH1A1 P00352 1/20 0.64
LMNA P02545 1/20 0.64
MAPT P10636 1/20 0.64
HPGD P15428 1/20 0.64
MAPK1 P28482 1/20 0.64
HTT P42858 1/20 0.64
RECQL P46063 1/20 0.64
MCL1 Q07820 1/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
L3MBTL1 Q9Y468 1/20 0.64
PIK3CA P42336 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL623771 1.00 GSK3B (1.00) GSK3BGSK3APIK3CGIGF1RINSR
SCHEMBL4206814 0.88 PIK3CG (1.00) GSK3BGSK3APIK3CGIGF1RINSR
SCHEMBL4206811 0.88 PIK3CG (1.00) GSK3BGSK3APIK3CGIGF1RINSR
SCHEMBL623774 0.86 IGF1R (1.00) GSK3BGSK3APIK3CGIGF1RINSR
SCHEMBL623776 0.86 IGF1R (1.00) GSK3BGSK3APIK3CGIGF1RINSR
SCHEMBL623775 0.86 IGF1R (1.00) GSK3BGSK3APIK3CGIGF1RINSR
SCHEMBL623633 0.85 PIK3CG (0.78) GSK3BGSK3APIK3CGIGF1RINSR
SCHEMBL623632 0.85 PIK3CG (0.78) GSK3BGSK3APIK3CGIGF1RINSR
SCHEMBL622538 0.82 PIK3CG (0.79) GSK3BGSK3APIK3CGIGF1RINSR
SCHEMBL622537 0.82 PIK3CG (0.79) GSK3BGSK3APIK3CGIGF1RINSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9255088-B2 Premature-termination-codons readthrough compounds THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-02-09 US disclosed
US-20130274283-A1 PREMATURE-TERMINATION-CODONS READTHROUGH COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-10-17 US disclosed
WO-2012021707-A2 PREMATURE-TERMINATION-CODONS READTHROUGH COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130274283-A1 PREMATURE-TERMINATION-CODONS READTHROUGH COMPOUNDS UPF1, NUDT21, RNGTT GSK3B 4721/4885GSK3A 4773/4885PIK3CG 3728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.